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Abstract
Background: Colorectal cancer screening participation is a preference-sensitive choice, in which trade-offs between
benefits and harms must be made by individual citizens. Often the decision is made without any contact with healthcare
professionals. Citizens with lower educational attainment tend to participate less in colorectal cancer screening
than citizens with average educational attainment. Further, they tend to have lower levels of knowledge about
colorectal cancer screening. Providing lower educational attainment citizens with a targeted decision aid embracing
their diverse information needs might increase these citizens’ ability to make informed decisions. The aim of this trial is
to test the effectiveness of such a newly developed self-administered decision aid.
Methods: The LEAD (Lower Educational Attainment Decision aid) trial will be conducted as a two-arm randomized
controlled trial among 10,000 50–74-year-old citizens, resident in the Central Denmark Region not yet invited to take
up colorectal cancer screening. Citizens will receive a baseline questionnaire. Respondents will be allocated into the
intervention or the control groups. Citizens in the intervention group will receive the decision aid whereas the control
group will not. Those who return a stool sample within 45 days after receiving the screening invitation and those with
medium or higher educational attainment are excluded. Both groups will receive a follow-up questionnaire 90 days
after being invited to colorectal cancer screening.
A historic cohort consisting of 5000 50–74-year-old citizens resident in the Central Denmark Region, having received
their screening invitation in the beginning of 2017 will be included. This cohort will receive a follow-up questionnaire
6–9 months after they received the screening invitation.
Informed choice will be evaluated by assessing levels of knowledge, attitudes, and screening uptake. Analyses will be
conducted as intention-to-treat analyses. Additionally, differences between levels of worry and decisional conflict
between groups will be assessed as secondary outcomes.
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Discussion: This trial will evaluate whether a targeted decision aid is a feasible way of enhancing informed choice among
lower educational attainment citizens in colorectal cancer screening. Further, it may guide decisions about providing
information material in cancer screening in general.
Trial registration: ClinicalTrials.gov, NCT03253888. Registered on 17 August 2017.
Keywords: Colorectal cancer, Cancer screening, Decision aid, Lower educational attainment, Randomized controlled trial,
Background
Colorectal cancer (CRC) is a common cause of cancer-
related deaths worldwide. In developed countries the
age-standardized mortality rate of CRC is 14.7 and 9.3
per 100,000 men and women, respectively [1]. However,
CRC mortality can be reduced by 25% in citizens under-
going screening with the guaiac fecal occult blood test
(gFOBT) at least once [2]. The fecal immunochemical
test (FIT) is superior to the gFOBT in detecting CRC
and is now the preferred test [3].
Screening has obvious benefits, including reduced inci-
dence of CRC, earlier stage diagnoses, and reduced mortal-
ity [2]. However, there are also adverse effects of screening,
such as risk of over-diagnosis, unnecessary tests and com-
plications to these, and psychological consequences. Hence,
a decision to take up screening is preference-sensitive and
includes a cognitive and emotional trade-off between
benefits and harms, based on adequate information [4].
From an ethical standpoint, such a decision should be an
informed decision.
In order to make an informed decision, comprehensible
and easily accessible information is crucial. However, in-
formation material about CRC screening is often neither
read nor understood by citizens with lower levels of health
literacy [5]. Low health literacy is significantly associated
with lower educational attainment [6]. In order to support
informed decision making, decision aids have been devel-
oped to provide balanced information on healthcare [7].
Decision aids come in different formats (e.g. booklet, leaf-
let, online service, DVD, etc.) and they may encourage
readers to reflect on the information in a structured way,
for example by the means of “values clarification exer-
cises” [8]. Studies have shown that decision aids can in-
crease CRC knowledge and the proportion of citizens
making an informed decision about screening uptake
when used by citizens and healthcare professionals to-
gether [9, 10]. Furthermore, they can increase screening
uptake [11–15]. However, the decision to take up CRC
screening is often made without prior contact with health-
care professionals, and hence, decision aids need to be
self-administered. Self-administered decision aids increase
CRC knowledge [16–20] and informed choices made [18,
19], but may result in more negative screening attitudes
[18, 19], while studies regarding screening uptake are
inconclusive [16, 18–20].
In general, lower educational attainment citizens par-
ticipate less in CRC screening compared with those who
have average educational attainment [21, 22]. Further,
they have higher CRC mortality compared to medium
and higher educational attainment citizens [23, 24]. Tai-
loring a decision aid to this group could be advanta-
geous, but their information needs are diverse, ranging
from a desire for a clear recommendation to the need to
know all the details [25]. Decision aids tailored to this
group do exist [9, 10, 13], but are not self-administered
[19], and none of them embrace diverse information and
support needs. Hence, this research group has developed
a decision aid tailored for lower educational attainment
citizens [26]. It was designed as an online format, pre-
senting information in steps, making it possible for citi-
zens to get as much or as little information as they
want, thereby embracing diverse information needs.
The aim of the LEAD (Lower Educational Attainment
Decision aid) trial is to investigate the effectiveness of
the newly developed decision aid tailored for lower edu-
cational attainment citizens on informed choice, as
assessed based on knowledge of CRC and CRC screen-
ing, CRC screening uptake, and CRC screening attitudes.
Further, the effectiveness on levels of CRC worries and
decisional conflict will be assessed.
Methods
Setting
CRC screening with biennial FIT was introduced in
Denmark in 2014 with an initial “prevalence round” of
invitations for four years, where all citizens aged 50–
74 years are invited once, according to month of birth.
Citizens turning 50 or 75 years during the prevalence
round are invited just before their birthday if not invited
earlier. From 2018, all citizens in the target group will
receive biennial invitations (identifying incident CRC).
The screening program is locally administered in five re-
gions. This study is carried out in the Central Denmark
Region, which is the second largest region with roughly
395,000 citizens aged 50–74 years [27].
In the CRC screening program, the mailed screening
invitation contains a screening kit (collection tube and
collection paper), instructions on how to obtain the sam-
ple, an official information leaflet, and a pre-stamped,
pre-addressed envelope. If a screening sample is not
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returned within 45 days, a digital reminder is sent (see
below). Test results are digitally mailed to the citizens
within one week after the test is received at the labora-
tory. Citizens with a negative test result are referred to
the next screening round (two-year interval) and citizens
with a positive test result receive an appointment for
colonoscopy. Non-participating citizens are automatic-
ally referred to the next screening round.
Danish residents are obliged to order a digital signa-
ture which is used to log in to a secure national e-mail
platform, where all mandatory digital communication
with Danish authorities (including hospitals) takes place
via the unique civil registration number. Some citizens
(8.7% of the population aged 45–74 years during the
summer of 2017 [28]) can be exempted from digital
communication [29] and receive conventional mail via a
remote printing system, in which an external supplier
prints out and sends all letters to exempted citizens.
Study design
The LEAD trial will be conducted as a two-armed,
randomized controlled trial nested into the Danish CRC
screening program in the Central Denmark Region. In-
cluded citizens will be randomly allocated to one of the
following two study arms (Fig. 1):
1. Screening reminder with the decision aid
(intervention group);
2. Screening reminder without decision aid
(usual care/control group).
The intervention and control groups receive the base-
line questionnaire before the screening invitation. This
might increase screening awareness and possibly screen-
ing uptake and knowledge in these groups – a true
Hawthorne effect. To be able to assess the effect of the
questionnaire, a historic cohort will be introduced as in
other decision aid trials [30]. This group will receive
their questionnaire after screening invitation and uptake
assessment.
This study entails evaluating the offer to use the deci-
sion aid. Even though participants may not necessarily
use it, not using the decision aid is not a specific issue in
this study as it is a pragmatic evaluation of offering it in
a routine screening program.
Study processes
Seven to 20 weeks before the invitation date, the in-
cluded citizens in study arms 1 and 2 will receive a link
to the baseline questionnaire via their digital mail (with
remote printing for exempted citizens). Questionnaire
reminders will be sent out after two weeks. Instead of a
second questionnaire reminder, non-respondents will be
contacted via telephone after four weeks and invited to
fill out the questionnaire via telephone interview. In a
pilot study, the response rates among lower educational
attainment and medium/higher educational attainment
citizens using an invitation and a two-week reminder
were assessed at 27% and 55%, respectively. The
response rates increased to 40% and 64%, respectively, in
the two groups, by using telephone interviews. Accord-
ingly, we expect telephone interviews to help reach more
of the lower educational attainment citizens. Question-
naire respondents will also be asked for consent to the
obtaining and analysis of screening data (date of
invitation, reminder, receipt of test in laboratory, and
test result) from the screening program database.
Citizens who respond to the questionnaire and give
consent to the use of registry data will be randomly
allocated into study arms 1 and 2. Allocation will be per-
formed in the ratio 1:1 and will use a computer-gener-
ated algorithm for randomization, based on a simple
randomization procedure. Randomization will be con-
ducted based on the study participants’ record-ID num-
bers. Participants will not be able to change study arm
after allocation and there will be no blinding.
Citizens who take up screening within 45 days after
the screening invitation and citizens with medium or
higher educational attainment (i.e. 10 years or more of
education) will be excluded from the analyses after
randomization. This might cause attrition bias. However,
randomization will be conducted externally before
screening uptake is known. Furthermore, educational at-
tainment will not be available to researchers at an indi-
vidual level, unless data are pseudonymized. However,
educational level and screening uptake within 45 days of
invitation is not expected to be associated with study
arm and, hence, no attrition bias is expected.
When citizens in the intervention group are due for a
screening reminder, they will concurrently receive a sep-
arate mail containing a link for the decision aid. This
strategy was chosen in order to avoid information over-
load, since other conventional information material is
sent out along with the screening invitation. Further,
first invitations are sent out by postal mail, and hence,
the link is better provided in the reminders that are sent
by digital mail.
Forty-five days after the citizens have received the
intervention/screening reminder, they will receive the
follow-up questionnaire. Reminder procedures for the
follow-up questionnaire will be the same as for the base-
line questionnaire. Citizens who do not return follow-up
questionnaires within six weeks (i.e. going to the last
page in the questionnaire and pressing submit) will be
excluded from the study, since the consent to use data
in the project will not have been given.
Citizens in the historic study arm will receive one ques-
tionnaire 6–8 months after being invited to participate in
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Fig. 1 Participant flow chart. Figure depicting the data collection, interventions, and participant flow in the trial
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CRC screening. Reminder procedures for this question-
naire will be the same as for the previous questionnaires.
Decision aid
The development of the decision aid was based on a
framework suggested by Coulter et al. [31], in accord-
ance with the IPDASi (the International Patient Decision
Aid Standards instrument) criteria [32]. The process
comprised six steps: (1) defining the purpose of the deci-
sion aid and the target population, i.e. decision about
CRC screening uptake in lower educational attainment
citizens; (2) formation of steering group, comprising
both screening experts and experts on shared decision
making (no citizens were included in the steering
group); (3) designing the decision aid, based on Danish
lower educational attainment citizens’ information
needs, as described in a previous study [25]; (4) alpha
testing the decision aid to check usability and design –
this step included both lower educational attainment
citizens and healthcare professionals and used both
focus group interviews and e-mail correspondence; (5)
external peer reviewing also included citizens and
healthcare professionals; and (6) the beta or user-testing
with lower educational attainment citizens assessed
feasibility, comprehensibility, and usability. Based on in-
puts from all steps, the final decision aid was completed
by a professional web design agency, supervised by the
steering group [26].
The decision aid is an online tool. The online design
was chosen, since digital communication is mandatory
in Denmark, and 91.3% of the population (aged 45–
74 years) has access to digital mail [28]. Further, the on-
line design opens up possibilities to feature more ad-
vanced functions, e.g. questions for the participant
during the process, and a summary of answers at the
end, presented as a “choice indicator.” The decision aid
consists of 15 steps in total. Each step presents facts in a
figure or chart and, via links in these, pop-ups with fur-
ther information are available. The figures used are icons
(e.g. illustrating colon with a polyp and cancer), pie
charts, crowd-figures, and a flow chart illustrating the
possible steps in CRC screening. Almost all pop-ups
have a “read more” function. The decision aid is avail-
able in Danish by contacting the authors.
Study population
Two samples of citizens will be provided by the Danish
Health Data Authority from the Danish Civil Registra-
tion System [33]: (1) a random sample of 10,000 53–
74-year-old citizens, born in December, and resident in
the Central Denmark region on 1 August 2017 (expected
to be invited for screening during October–December
2017); and (2) a random sample of 5000 50–74-year-old
citizens, born in October, and resident in the Central
Denmark Region on 1 August 2017 (invited for screen-
ing during January–March 2017) for the historic study
arm (Fig. 1). The lists will contain civil registration num-
ber, name, and postal address of the sampled citizens.
No incentives are used in this trial.
Outcomes
The outcomes assessed in this trial are presented in
Table 1.
Primary outcome
Informed choice will be evaluated based on the following
primary outcomes: consistency of knowledge about CRC
screening, attitudes towards CRC screening, and screen-
ing uptake [34].
Knowledge will be measured via questionnaire before
and after intervention using a seven-item scale devel-
oped by the authors based on both a literature search
and patient information needs as previously clarified in
focus group interviews [25]. Post-intervention levels and
changes from baseline to follow-up will be evaluated.
Screening attitudes will be estimated using the trans-
lated four-item attitudes scale, ranging from 4 to 28
points [34]. The scale has been translated into Danish
from English with conventional forward-backward trans-
lation [35]. Attitudes will be assessed at baseline and at
follow-up.
Data on screening uptake will be collected from the
CRC screening program database. Citizens will be
defined as having taken up CRC screening if they return
a stool sample within three months (90 days) after the
screening invitation has been sent out [36].
Secondary outcomes
The 16-item decisional conflict scale [37] will be used
to measure decisional conflict, i.e. uncertainty about
making the right choice. It comprises five subscales,
including the decisional support subscale and the
(perceived) effectiveness of the decision subscale.
Scores range from 0 to 100 and data are collected at
follow-up.
Worry about CRC will be assessed using three items
on worry about CRC. Two items assess worry and anx-
iety when considering CRC screening and one assesses
worry about the result of a screening test. Items have
also been developed by the authors based on literature
searches [19, 20, 38–40]. Scores are in the range of
3–15. Assessments are made at baseline and follow-up.
Health literacy is a multidimensional measure of a per-
son’s ability to access, understand, appraise, and apply
information about healthcare, disease prevention, and
health promotion [41]. It will be measured at baseline
using the 16-item HLS-EU-Q16 scale [41].
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The use of the decision aid will be measured among
citizens receiving an invitation to use it. However,
detailed process data will not be collected, since the
primary aim of this trial is to investigate the effective-
ness of having the decision aid provided, regardless of
actually reading it. Usability and acceptability have been
further assessed in the development phase of the deci-
sion aid [26].
Background data
Background data on participants’ sociodemographic and
socioeconomic characteristics will be obtained from Sta-
tistics Denmark [42] by the end of the study period.
These data are updated annually.
Lower educational attainment is defined according to
the UNESCO classification of basic education as < 10 years
of education [43].
Family income will be divided into three categories
based on lower, middle, and upper tertiles of the dataset.
Occupation is a categorical variable with the following
six categories: Employed; Self-employed/chief executive;
Unemployed/receiving benefits; Retired; Social welfare
recipients; and Others. Marital status is dichotomized
into two categories: married/cohabitant and single. Eth-
nicity will be a categorical variable with three categories:
Danish; Western immigrant (Western Europe and North
America); and non-Western immigrant (Table 1).
Questionnaires
Three different questionnaires will be administered in
this trial: the baseline (knowledge, seven items; atti-
tudes, four items [34]; worry, three items; health liter-
acy – HLS-EU-Q16, 16 items [41, 44]) and follow-up
(knowledge; attitudes; worry; decisional conflict, 16 items
[37]) questionnaires, and the questionnaire for the historic
study arm participants (knowledge; attitudes; worry;
health literacy; decisional conflict) (Fig. 2).
All questionnaires will be administered via REDCap
Software (Version 6.12.0 - © 2016 Vanderbilt University)
[45]. Data entry will occur automatically when the citi-
zens complete the electronic questionnaires, hence no
manual data entry will be required. The questionnaires
are presented in Additional files 1, 2 and 3.
Statistical methods
All statistical analyses will be carried out in Stata/SE 14
(STATACorp LP, College Station, TX, USA). Analyses will
be carried out on a 5% significance level, stratified to
gender. Estimates will be presented with 95% confidence
intervals. Intention-to-treat analyses will be conducted.
Table 1 Trial outcomes
Outcome Characteristics Assessment time Comparisonsa Null Hypothesisa
Primary outcome (Informed choice elements)
Knowledge Numeric scale Baseline 1 vs. 2 No difference
Numeric scale DifFollow-up-baseline
b 1 vs. 2 1 > 2
Numeric scale Follow-up 1 vs. 2 vs H 1 > 2 and 1 > H
Attitudes Numeric scale Baseline 1 vs. 2 No difference
Numeric scale DifFollow-up-baseline
b 1 vs. 2 No difference
Uptake Dichotomous Follow-up 1 vs. 2 vs H 1 > 2 and 1 > H
Secondary outcomes
Decisional conflict Numeric scale Follow-up 1 vs. 2 vs H 1 < 2 and 1 < H
Worry Numeric scale Baseline 1 vs. 2 vs H No difference
Numeric scale DifFollow-up-Baseline
b 1 vs 2 1 < 2
Effect modifiers and confounders
Health literacy Numeric scale Baseline 1 vs. 2 vs. H No difference
Background data
Family income Categorical Post survey 1 vs. 2 vs. H No difference
Occupation Categorical Post survey 1 vs. 2 vs. H No difference
Marital status Dichotomous Post survey 1 vs. 2 vs. H No difference
Ethnicity Categorical Post survey 1 vs. 2 vs. H No difference
H historic study arm
aGroup 1 refers to the intervention group and group 2 refers to the control group
bDifFollow-up-Baseline: The mean increase or decrease in knowledge, attitude, and worry-score from baseline to follow-up will be estimated. Means will be compared
between the two study arms
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Pearson’s chi-square test will be used to test differences
in demographic characteristics between respondents and
non-respondents as well as between those included in
each study arm with lower educational attainment, in
order to test for baseline differences. Furthermore,
differences in educational attainment and screening up-
take within 45 days in each study arm will be compared in
order to evaluate the risk of attrition bias.
The main outcome of the trial is informed choice. In-
formed choice is difficult to measure and the evaluation
Fig. 2 Schedule of enrolment, intervention, and assessments. Figure depicting the enrolment, intervention, and assessments according to SPIRIT
2013 statement [46]. § Assessed only in the historic cohort. BD background data, obtained from Statistics Denmark. Follow-up occurs throughout
a period of 12 weeks. The final data will be obtained from the screening program IT system when all follow-up data have been collected. The
complete data will then be merged with background data from Statistics Denmark
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will be based on adequate knowledge about CRC screen-
ing and consistency between attitudes towards CRC
screening and screening uptake. This will be judged at
group level not individual level. [46] Differences in
distributions of responses to knowledge, attitudes, up-
take, decisional conflict, and worries in the study arms
will be analyzed using the independent sample t-test for
continuous variables and Pearson’s chi-square test for
categorical variables. The relative risk (RR) will be esti-
mated for uptake using a logistic regression analysis with
study arm 2 as the reference comparing to both study
arm 1 and the historic cohort. Citizens are defined as
having taken up CRC screening if they returned a stool
sample within three months after the screening invita-
tion was sent out [47]. For the numeric scale outcomes,
a linear regression analysis will be conducted to compare
the means between study arms 1 and 2 and study arm 2
and the historic cohort, using study arm 2 as the refer-
ence. For ordinal scales, not normally distributed as
assessed by histograms and qq-plots, ordinal regres-
sion analyses will be conducted, estimating odds ra-
tios for higher scores in study arm 1 and the historic
cohort as compared to study arm 2, using study arm
2 as the reference.
Further, generalized linear models from the binary
family will be conducted to test if socioeconomic vari-
ables (including health literacy) modify the effectiveness
of the decision aid on knowledge, attitudes, and uptake.
P values for these analyses will be estimated using the
Wald test.
Few missing data are expected in registry and IT sys-
tem data, since these systems are almost 100% complete
[48]. Missing data may occur with the questionnaire
data. In the scoring of health literacy, no more than
three missing out of 16 items is accepted, otherwise the
score cannot be calculated [41]. This is in contrast to
the decisional conflict scale, in which the number of
missing items is considered when calculating the final
score [37]. In the knowledge scale, all questions are mul-
tiple choices and the response category “I don’t know” is
represented in every item, giving the respondents a pos-
sibility to answer even if they are in doubt. The answer
“I don’t know” and missing values are coded as wrong
answers in the final scoring.
Power calculations
The smallest difference between outcomes between
groups is expected to be found in attitudes estimates (a
14% difference in proportions having a positive attitude
towards screening [19]) Based on this assumption, power
calculations (considering a 5% significance level and an
80% statistical power) indicate that we need to include
200 citizens with lower educational attainment in each
group. We expect 47% of citizens invited to CRC
screening not to return a stool sample within 45 days. Fur-
ther, we know that 26% of the population has lower edu-
cational attainment [49]. By combining mailed invitations
and reminders with telephone calls, we aim to reach a re-
sponse rate of at least 60% for baseline questionnaire and
80% for follow-up (i.e. study participants). Further, we ex-
pect a 50% response rate in the historic study arm. In
order to be able to make gender stratified analyses, and
considering the rate of screening reminder, rate of lower
educational attainment, and questionnaire response rate,
we need to include 5000 citizens in each study arm.
Discussion
The decision to take up CRC cancer screening is a
preference-sensitive choice. The decision is often made
without prior contact with healthcare professionals, and
hence, comprehensible and accessible information mater-
ial is crucial. Currently this type of information material is
lacking, especially for lower educational attainment citi-
zens, who also have the lowest screening uptake. Our
newly developed decision aid is designed to provide lower
educational attainment citizens with accessible and com-
prehensible information to support informed choice about
taking up screening. Further, the decision aid is easy to
implement directly into the existing screening program,
through the national electronic mail system, should it be
shown effective on our key outcomes. Preferably, all deci-
sions about screening uptake and non-uptake should be
informed. In this trial, we investigate whether non-uptake
is informed and can be supported. However, the follow-up
questionnaire will be sent out to screening participants as
well as non-participants. In a future study, it will be pos-
sible to investigate whether screening uptake was in-
formed. By nesting the effectiveness study into an existing
screening program using registry data of high quality and
with almost 100% coverage [48], the results of this study,
combined with future information about the level of in-
formed choices of uptake and non-uptake, may provide a
basis for recommendations about targeted information
material in CRC screening in particular and guide future
information and decision support material in cancer
screening in general.
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Additional file 3: Questionnaire for the historic cohort. (DOCX 37 kb)
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